Volume 14, Issue 1 (5-2000)                   Med J Islam Repub Iran 2000 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

SAADATNIA H, SERESHKI S, GHIASI MOGHADAM T. PRIMARY MALIGNANT TUMORS OF THE SMALL INTESTINE: ANALYSIS OF 156 IRANIAN PATIENTS. Med J Islam Repub Iran 2000; 14 (1) :5-8
URL: http://mjiri.iums.ac.ir/article-1-891-en.html
From the Departments of Medicine and Pathology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran.
Abstract:   (4393 Views)
156 Iranian patients with primary malignant tumors of the small intestine were reviewed. Malignant lymphoma was the most common tumor type, comprising 128 patients (82%), followed by adenocarcinoma (22 patients, 14.1 %), leiomyosarcoma (4 patients, 2.56%) and carcinoid tumor (2 patients, 1.28%). Lymphomas and adenocarcinomas were primarily located in the duodenum or jejunum, whereas leiomyosarcomas were more cornmon in the ileum. Abdominal pain (73%), weight loss (68%), diarrhea (41% ), and nausea or vomiting (35%) were the most common symptoms with these tumors. Among the lymphoma group 95 patients (74.2%) had non-IPSID (immunoproliferative small intestinal disease) lymphoma and 33 patients (25.8%) had IPSID related lymphoma. In contrast to the western world and far east countries in which malignant small intestinal tumors are a disease of middle and old age groups and adenocarcinoma is the most common tumor type, in our area, similar to some other middle east and north African countries, lymphomas are much more frequent. Although Iran is endemic for IPSID related lymphoma, the majority of these tumors are non-IPSID lymphomas and appear in a very young age group (mean age 27 y).
Full-Text [PDF 352 kb]   (1233 Downloads)    
Type of Study: Original Research | Subject: Pathology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.